Knight Therapeutics Inc. (KHTRF)
OTCMKTS
· Delayed Price · Currency is USD
4.040
0.00 (0.00%)
Oct 29, 2024, 4:00 PM EDT
Knight Therapeutics Employees
Knight Therapeutics had 725 employees as of December 31, 2023. The number of employees increased by 27 or 3.87% compared to the previous year.
Employees
725
Change (1Y)
27
Growth (1Y)
3.87%
Revenue / Employee
$340,506
Profits / Employee
-$21,391
Market Cap
406.28M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Sandoz Group AG | 22,633 |
Telix Pharmaceuticals Limited | 234 |
Elekta AB (publ) | 4,718 |
Ryman Healthcare Limited | 7,700 |
Verano Holdings Corp. | 3,900 |
Vireo Growth Inc. | 490 |
Medexus Pharmaceuticals Inc. | 82 |
Knight Therapeutics News
- 4 weeks ago - Knight Therapeutics Inc. places No. 397 on The Globe and Mail’s sixth annual ranking of Canada’s Top Growing Companies - Financial Post
- 4 weeks ago - Knight Therapeutics Inc. places No. 397 on The Globe and Mail's sixth annual ranking of Canada's Top Growing Companies - GlobeNewsWire
- 7 weeks ago - Andrey Omelchak's Top Picks:Lumine, Trisura Group, and Knight Therapeutics - BNN Bloomberg
- 3 months ago - Knight Therapeutics Reports Second Quarter 2024 - GlobeNewsWire
- 3 months ago - Notice of Knight Therapeutics' Second Quarter 2024 Results Conference Call - GlobeNewsWire
- 6 months ago - Knight Therapeutics, Inc. (KHTRF) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Knight Therapeutics Reports First Quarter 2024 Results - GlobeNewsWire
- 6 months ago - Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Ironshore Pharmaceuticals & Development, Inc. for JORNAY PM® for Canada and Latin America - GlobeNewsWire